Table 1 Participants’ demographic and clinical characteristics (n = 121)
Characteristics | Values |
|---|---|
Age (years) | 58.5 ± 10.5 |
T2DM duration (years) | 11.6 ± 7.5 |
Duration of metformin use (years) | 9.6 ± 6.8 |
Total daily dose of metformin (gram) | 2.4 ± 0.7 |
Cumulative dose of metformin (gram) | 23.7 ± 18.2 |
eGFR (mL/min/1.73 m2) | 116.7 ± 44.6 |
Women, n(%) | 80(66) |
HbA1c (mmol/mol) [%] | 76 ± 27 [9.1 ± 2.5] |
Smokers, n(%) | 8(6.6) |
Insulin use, n(%) | 96(79.3) |
Alcohol consumption, n(%) | 4(3.3) |
Coffee consumption, n(%) | 23(19) |
Race | |
Black, n(%) | 89(73.5) |
Non-black, n(%) | 32(26.5) |
Number of daily metformin doses | |
One, n(%) | 3(2.5) |
Two, n(%) | 61(51.2) |
Three, n(%) | 55(46.2) |
Acetylsalicylic acid use, n(%) | 94(77.7) |
PPIs or H2RAs use, n(%) | 12(10) |
BMI (kg/m2) | 33.4 ± 6.3 |
Vitamin B12 levels (pmol/L) | 260.6 ± 163.7 |
NTSS-6 Scores | 5.11 ± 3.86 |